K. G. Jebsen Centre for Alzheimer’s Disease

K. G. Jebsen Centre for Alzheimer’s Disease (JCA)

K. G. Jebsen Centre for Alzheimer’s Disease (JCA)


K. G. Jebsen Centre for Alzheimer’s Disease is a national research centre of interdisciplinary experts united in the common goal of determining the onset of Alzheimer's and the early stages of disease development.

The vision of the Jebsen centre is to translate Nobel Prize winning research from laboratory to patient. To accomplish this, the Jebsen team of experts collaborate on a set of projects designed to bridge the gaps from basic science to clinical implementation.

The centre activities span from basic research in rats and mice to clinical research in humans. Each step, from the lab to the patient, is quality assured with what is called translational research. Here, promising basic research results on healthy brains are translated to brains that have been affected by Alzheimer's disease, and the most significant findings from human brain disease are translated into animal models for testing before findings are reintroduced to humans.

Large-scale collaboration

Bringing together scientists across disciplines, the Jebsen Centre will establish a network of scientists to foster a healthy scientific discourse and to provide the society with quality assured scientific facts about Alzheimer's disease and the brain.

The centre is a large-scale collaboration that unites university and hospital and links them with prominent national and international partners. Jebsen researchers have access to state-of-the art technology from the NORBRAIN 2 and NORBRAIN 3 research infrastructure programmes.

The centre was made possible by a donation from the Foundation Stiftelsen Kristian Gerhard Jebsen of NOK 22.5 million. The Foundation Stiftelsen Kristian Gerhard Jebsen aims to support new and promising research that may ultimately lead to improved treatments for patients. They have established 22 K. G. Jebsen centres for medical research in collaboration with Norwegian universities and university hospitals.

The Central Norway Regional Health Authority has contributed NOK 11.25 million and NTNU's Faculty of Medicine and Health Sciences has contributed NOK 5.63 million. St. Olavs hospital and the National Association for Public Health, with its expertise and close contact with patients and relatives, will collaborate closely with the centre.

Read the news article: 

Norway’s Nobel laureates take up the fight against Alzheimer's



Location of JCA

The K.G. Jebsen Centre for Alzheimer’s Disease is a compact centre of units co-localized within a radius of 300 meters at St. Olav's Hospital in Trondheim, Norway.